{"id":977,"date":"2022-02-08T15:03:40","date_gmt":"2022-02-08T15:03:40","guid":{"rendered":"http:\/\/albergueweb1.uva.es\/cesme\/?page_id=977"},"modified":"2025-03-26T19:44:00","modified_gmt":"2025-03-26T19:44:00","slug":"publicaciones","status":"publish","type":"page","link":"https:\/\/albergueweb1.uva.es\/cesme\/publicaciones\/","title":{"rendered":"Publicaciones"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_column_text]<nav aria-label=\"breadcrumbs\">\n            <div class=\"breadcrumb-container theme1\">\n                <ol>\n                                    <\/ol>\n            <\/div>\n        <\/nav>    <script type=\"application\/ld+json\">\n        {\n            \"@context\": \"http:\/\/schema.org\",\n            \"@type\": \"BreadcrumbList\",\n            \"itemListElement\": [\n                            ]\n        }\n    <\/script>\n   \n    <script>\n            <\/script>\n[\/vc_column_text][vc_column_text]\n<h1>Publicaciones<\/h1>\n<h2>Libros y cap\u00edtulos de libros<\/h2>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Salgueiro ME, Gil MA, Jimeno FJ, Perez B, S\u00e1inz M, Esteban C. <strong>La farmacovigilancia y los profesionales sanitarios<\/strong>. En: Los primeros 25 a\u00f1os del Sistema Espa\u00f1ol de Farmacovigilancia de Medicamentos de Uso Humano. Oviedo: Universidad de Oviedo; 2010 p. 93-120.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><strong>Art\u00edculos cient\u00edficos<\/strong><\/h2>\n<h3><strong>2025<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Yuste, M.T., Sainz-Gil, M., Escudero, E. and Mar\u00edn, P. (2025), Dementia and Alzheimer&#8217;s Disease Associated With Aromatase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase). Pharmacol Res Perspect, 13: e70075. <a href=\"https:\/\/doi.org\/10.1002\/prp2.70075\">https:\/\/doi.org\/10.1002\/prp2.70075<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2024<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Garc\u00eda M, Albizua Madariaga I, Sainz-Gil M, Lertxundi U. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database. Br J Clin Pharmacol. 2024; 1-5. doi:<a href=\"https:\/\/doi.org\/10.1111\/bcp.16117\">10.1111\/bcp.16117<\/a><\/li>\n<li>Est\u00e9vez Asensio L, Garc\u00eda M, Verde Rello Z, Velasco-Gonz\u00e1lez V, Fern\u00e1ndez-Araque AM, Sainz-Gil M. Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis. Med Clin (Barc). 2024;163(12):600-8. doi:10.1016\/j.medcli.2024.07.021<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2023<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Mar\u00eda Sainz-Gil, Nieves Merino Kolly, Ver\u00f3nica Velasco-Gonz\u00e1lez, Zoraida Verde Rello, Ana M Fernandez-Araque, Rosario Sanz Fadrique &amp; Luis H Mart\u00edn Arias. Hydroxychloroquine safety in Covid-19 vs non-Covid-19 patients: analysis of differences and potential interactions, Expert Opinion on Drug Safety 2023;22(1):71-79. DOI: <a href=\"https:\/\/doi.org\/10.1080\/14740338.2022.2078303\">10.1080\/14740338.2022.2078303<\/a><\/li>\n<li>Fern\u00e1ndez-Araque A, Verde Z, Torres-Ortega C, Sainz-Gil M, Velasco-Gonzalez V, Gonz\u00e1lez-Bernal JJ, Mielgo-Ayuso J. Effects of Antioxidants on Pain Perception in Patients with Fibromyalgia\u2014A Systematic Review. <em>Journal of Clinical Medicine<\/em>. 2022; 11(9):2462. <a href=\"https:\/\/doi.org\/10.3390\/jcm11092462\">https:\/\/doi.org\/10.3390\/jcm11092462<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2022<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Mart\u00edn, L.H., Sainz-Gil, M., Navarro-Garc\u00eda, E. , Salado-Valdivieso, I., Sanz-Fadrique, R. Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database. Drugs &#8211; Real World Outcomes (2022). <a href=\"https:\/\/doi.org\/10.1007\/s40801-021-00282-3\">https:\/\/doi.org\/10.1007\/s40801-021-00282-3<\/a><\/li>\n<li>Narmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, Eguzki\u00f1e Ibarra-Garc\u00eda, Itziar Palacios-Zabalza, Fernando Mac\u00edas-Garc\u00eda, Mar\u00eda Pi\u00f1eiro-Lamas, Luisa Ib\u00e1\u00f1ez, Xavier Vidal, Lourdes Vendrell, Luis Martin-Arias, Mar\u00eda S\u00e1inz-Gil, Ver\u00f3nica Velasco-Gonz\u00e1lez, Manuel Bacariza-Corti\u00f1as, Angel Salgado, Ana Estany-Gestal &amp; Adolfo Figueiras on behalf of the EMPHOGEN Group.\u00a0<span lang=\"EN-GB\">Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study.\u00a0<\/span>Annals of Medicine 2022;54(1):379-92.\u00a0<a href=\"https:\/\/doi.org\/10.1080\/07853890.2021.2016940\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/doi.org\/10.1080\/07853890.2021.2016940&amp;source=gmail&amp;ust=1644496372484000&amp;usg=AOvVaw2FdCgEuVxuB1wea33sGmjA\">https:\/\/doi.org\/10.1080\/<wbr \/>07853890.2021.2016940<\/a><\/li>\n<li>LH Mart\u00edn, M Sainz\u2011Gil, E Navarro\u2011Garc\u00eda, I Salado\u2011Valdivieso, R Sanz\u2011 Thromboembolism and Oral Contraceptives During the COVID\u201119 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database. Drugs &#8211; Real World Outcomes. DOI:\u00a0<a href=\"https:\/\/doi.org\/10.1007\/s40801-021-00282-3\">https:\/\/doi.org\/10.1007\/s40801-021-00282-3<\/a>.<\/li>\n<li>Fern\u00e1ndez-Araque A, Giaquinta-Aranda A, Moreno-Sainz C, Mart\u00ednez-Mart\u00ednez MC, Velasco-Gonz\u00e1lez V, Sainz-Gil M, Mart\u00edn-Arias LH, Carretero-Molinero S, Garc\u00eda-Hidalgo M, Verde Z. Haplotypes in the GC, CYP2R1 and CYP24A1 Genes and Biomarkers of Bone Mineral Metabolism in Older Adults. Nutrients. 2022; 14(2):259. DOI:\u00a0<a href=\"https:\/\/doi.org\/10.3390\/nu14020259\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3390\/nu14020259<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2021<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Natalia Jimeno, Veronica Velasco\u2011Gonzalez, Inmaculada Fierro, Mercedes Duran, Alfonso Carvajal. Association of CNR1 and INSIG2 polymorphisms with antipsychotics\u2011induced weight gain: a prospective nested case\u2013control study.\u00a0\u00a0 Sci Rep . 2021 Jul 27;11(1):15304. DOI: <a href=\"https:\/\/doi.org\/10.1038\/s41598-021-94700-9\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1038\/s41598-021-94700-9<\/a>.<\/li>\n<li>Mallah, N., Zapata-Cachafeiro, M., Aguirre, C. et al. A multicenter case\u2013control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users. Sci Rep 11, 19923 (2021). DOI: <a href=\"https:\/\/doi.org\/10.1038\/s41598-021-99402-w\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1038\/s41598-021-99402-w<\/a>.<\/li>\n<li>Velasco-gonz\u00e1lez V, Loya-p\u00e9rez L, Navarro-garc\u00eda E, Sainz-Gil M. Notificaci\u00f3n de sospechas de reacciones adversas a medicamentos por enfermeras en Espa\u00f1a. Un estudio observacional descriptivo retrospectivo. Enfermer\u00eda Cl\u00ednica 2021;31(6):363-70. DOI: <a href=\"https:\/\/doi.org\/10.1016\/j.enfcli.2020.10.033\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1016\/j.enfcli.2020.10.033<\/a>.<\/li>\n<li>Lecaros-Astorga DA, Molina-Guarneros JA, Rodr\u00edguez-Jim\u00e9nez P, Martin-Arias LH, Sainz-Gil M. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case\/non-case study. Int J Clin Pharmacol Ther. 2021;59(4):280-8. DOI: <a href=\"https:\/\/doi.org\/10.5414\/CP203769\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.5414\/CP203769<\/a>.<\/li>\n<li>Santos-P\u00e9rez MI, Fierro I, Salgueiro-V\u00e1zquez ME, Sainz-Gil M, Mart\u00edn Arias LH et al. A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use. European Journal of Hospital Pharmacy. 2021; 28(2): 88-93. DOI:\u00a0<a href=\"https:\/\/doi.org\/10.1136\/ejhpharm-2019-001927\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1136\/ejhpharm-2019-001927<\/a>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2020<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Ver\u00f3nica Velasco-Gonz\u00e1lez, Ana Fern\u00e1ndez-Araque, Maria Sainz-Gil, Natalia Jimeno, Luis H. Mart\u00edn, Zoraida Verde. Hydroxychloroquine and Potential Drug Interactions in Older Adults. Archivos de Bronconeumolog\u00eda (Engl. Ed.) 2020;56(10):670\u2013683. DOI:\u00a0<a href=\"https:\/\/doi.org\/10.1016\/j.arbres.2020.06.001\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1016\/j.arbres.2020.06.001<\/a>.<\/li>\n<li>Narmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, Eguzki\u00f1e Ibarra-Garc\u00eda, Itziar Palacios\u2013Zabalza, Fernando Mac\u00edas-Garc\u00eda, J. Enrique Dom\u00ednguez-Mu\u00f1oz, Mar\u00eda Pi\u00f1eiro-Lamas, Luisa Ib\u00e1\u00f1ez, Xavier Vidal, Lourdes Vendrell, Luis Martin-Arias, Mar\u00eda Sainz-Gil, Ver\u00f3nica Velasco-Gonz\u00e1lez and Adolfo Figueiras on behalf of the EMPHOGEN group. Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study. Pharmacol. 11:860. 09 June 2020 |. DOI:\u00a0<a href=\"https:\/\/doi.org\/10.3389\/fphar.2020.00860\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3389\/fphar.2020.00860<\/a>.<\/li>\n<li>Molina-Guarneros JA, Sainz-Gil M, Sanz-Fadrique R, et al. Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases. Int J Clin Pharm. 2020;42(2):713\u2010720. DOI:\u00a0<a href=\"https:\/\/doi.org\/10.1007\/s11096-020-01003-6\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1007\/s11096-020-01003-6<\/a>.<\/li>\n<li>S\u00e1inz\u2010Gil, M., Rodr\u00edguez\u2010Jim\u00e9nez, P., C\u00e1rdaba, M. and Mart\u00edn Arias, L. Kaposi sarcoma in patients on tumour necrosis factor alpha inhibitors: a case\u2013noncase study. J Eur Acad Dermatol Venereol. 2020;34: e156-e158. DOI: <a href=\"https:\/\/doi.org\/10.1111\/jdv.16087\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1111\/jdv.16087<\/a>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2019<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Manso G, Neira F, Ortega S, H. Mart\u00edn L, S\u00e1inz M, Salgueiro E. Medicines under additional monitoring in the European Union. Farm Hosp. 2019;43(1):19-23. DOI: <a href=\"https:\/\/doi.org\/10.7399\/fh.11041\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.7399\/fh.11041<\/a>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2018<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>LH Martin Arias, A Martin Gonzalez, R Sanz F, E Salgueiro, M Sainz. Cardiovascular and gastrointestinal safety of selective cyclooxygenase\u20112 inhibitors: a case\/non\u2011case study. International Journal of Clinical Pharmacy (2018) 40:928\u201335. DOI: <a href=\"https:\/\/doi.org\/10.1007\/s11096-018-0705-x\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1007\/s11096-018-0705-x<\/a>.<\/li>\n<li>Luis H. Mart\u00edn Arias, Rosario Sanz Fadrique, Susana P\u00e9rez Garc\u00eda, Mar\u00eda S\u00e1inz Gil, Carlos Trece\u00f1o Lobato, Pilar Garc\u00eda Ortega. Antipsychotics and cardiovascular risk: A case\/non-case study. Psychiatry Research 2018; 270: 341\u20137. DOI: <a href=\"http:\/\/doi.org\/10.1016\/j.psychres.2018.09.014\" target=\"_blank\" rel=\"noopener\">http:\/\/doi.org\/10.1016\/j.psychres.2018.09.014<\/a>.<\/li>\n<li>Santos-P\u00e9rez MI, Fierro I, Salgueiro-V\u00e1zquez ME, Gallardo-Lavado MDM, S\u00e1inz-Gil M, Mart\u00edn-Arias LH. A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors. Int J Clin Pharmacol Ther. 2018;56(12):577-84. DOI: <a href=\"http:\/\/doi.org\/10.5414\/CP203238\" target=\"_blank\" rel=\"noopener\">http:\/\/doi.org\/10.5414\/CP203238<\/a>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2017<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Mart\u00edn Arias LH, Sanz Fadrique R, S\u00e1inz Gil M, Salgueiro-Vazquez ME. Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations. Vaccine 2017;35(37):4870-4876. DOI: <a href=\"http:\/\/doi.org\/10.1016\/j.vaccine.2017.07.055\" target=\"_blank\" rel=\"noopener\">http:\/\/doi.org\/10.1016\/j.vaccine.2017.07.055<\/a>.<\/li>\n<li>Mart\u00edn Arias LH, Garc\u00eda Ortega P, S\u00e1inz Gil M, Navarro Garc\u00eda E, Trece\u00f1o Lobato C, Delgado Armas V. Atypical Fracture of the Sternum After Long-Term Alendronate Plus Cholecalciferol Treatment: A Case Report. Drug Saf &#8211; Case Rep 2017;4(1):5.<\/li>\n<li>Salgueiro-V\u00e1zquez ME, S\u00e1inz Gil M, Fern\u00e1ndez Pe\u00f1a S, Mart\u00edn Arias LH. Medication errors associated with oral administration of methotrexate. Data from spontaneous reporting and medical literature review. Med Clin (Barc) 2017;148(7):330-2.<\/li>\n<li>Mart\u00edn Arias LH, Trece\u00f1o Lobato C, P\u00e9rez Garc\u00eda S, S\u00e1inz Gil M, Sanz Fadrique R, Garc\u00eda Ortega P. Risk excess of mortality and use of antipsychotics: a case-non case study. Int Clin Psychopharmacol. 2017;32(1):1-5.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2016<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>H. Mart\u00edn Arias, C. Trece\u00f1o Lobato, S. P\u00e9rez Garc\u00eda, P. Garc\u00eda Ortega, M. S\u00e1inz Gil, R. Sanz Fadrique, A. Carvajal Garc\u00eda-Pando. Impact of regulatory measures on antipsychotics drug consumption in Castilla y Leon, Spain. Public Health 2016; 141: 113-9.<\/li>\n<li>Carvajal A, Mart\u00edn Arias LH, S\u00e1inz M, Escudero A, Fierro I, Sauzet O, Cornelius VR, Molokhia M. Carpal Tunnel Syndrome Associated with Oral Bisphosphonates. A Population-Based Cohort Study. PLoS One. 2016 Jan 14;11(1):e0146772. doi: 10.1371\/journal.pone.0146772. eCollection 2016. PubMed PMID: 26765346; PubMed Central PMCID: PMC4713232.<\/li>\n<li>Adolfo Figueiras, Ana Estany-Gestal, Carmelo Aguirre, Borja Ruiz, Xavier Vidal, Alfonso Carvajal, In\u00e9s Salado, Angel Salgado-Barreira, Luca Rodella, Ugo Moretti and Luisa Ib\u00e1\u00f1ez; on behalf of the EMPHOGEN group. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case\u2013control study. Pharmacogenetics and Genomics 2016, 26:66\u201373.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2015<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Mart\u00edn Arias LH, Sanz R, S\u00e1inz M, Trece\u00f1o C, Carvajal A. Guillain-Barr\u00e9 syndrome and influenza vaccines: A meta-analysis. Vaccine 2015;33(31):3773-8.<\/li>\n<li>Carvajal A, S\u00e1inz M, Velasco V, Garc\u00eda Ortega P, Trece\u00f1o C, Mart\u00edn Arias LH, Pell\u00f3n M, Garc\u00eda Sevillano L. Emergency contraceptive pill safety profile. Comparison of the results of a follow-up study to those coming from spontaneous reporting. Pharmacoepidemiol Drug Saf 2015; 24(1):93-7.<\/li>\n<li>Carvajal A. Temozolomide and oesophagitis. WHO Pharmaceuticals Newsletter 2015; 5: 19-22. <a href=\"http:\/\/www.who.int\/medicines\/publications\/pharmnewsletter5-2015.pdf\">http:\/\/www.who.int\/medicines\/publications\/pharmnewsletter5-2015.pdf<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2014<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Francisco J. Jimeno, Esther Salgueiro-Vazquez, Luc\u00eda Ordo\u00f1ez, Carmelo Aguirre, Alfonso Carvajal and Gloria Manso. Reporting problems related to medications in Spain. The yonotifico (I report) project, an option for citizens Intern. Journal of Clinical Pharmacology and Therapeutics 2014;52(12):1112-4.<\/li>\n<li>Montastruc F, Scotto S, Vaz IR, Guerra LN, Escudero A, S\u00e1inz M, Falomir T, Bagheri H, Herdeiro MT, Venegoni M, Montastruc JL, Carvajal A. Hepatotoxicity Related to Agomelatine and Other New Antidepressants: A Case\/Noncase Approach With Information From the Portuguese, French, Spanish, and Italian Pharmacovigilance Systems. J Clin Psychopharmacol 2014 Jun;34(3):327-30.<\/li>\n<li>Lapeyre-Mestre M, Gony M, Carvajal A, Macias D, Conforti A, D\u2019Incau P, Heerdink R, Van der Stichele R, Bergman U. A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions. Eur Addict Res. 2014;20(4):174-82.<\/li>\n<li>Garc\u00eda Sevillano L, Pell\u00f3n M, Trece\u00f1o C, S\u00e1inz M, Salado I, Vel\u00e1sco V, Jim\u00e9nez Serran\u00eda MI, Carvajal A. Knowledge upon the emergency contraceptive pill in spain. European Journal of Clinical Pharmacy 2014;16(3):224-8.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2013<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Mart\u00edn Arias, C. Trece\u00f1o, P. Garc\u00eda-Ortega, J. Rodr\u00edguez-Paredes, A. Escudero, M. S\u00e1inz, I. Salado, V. Velasco, A. Carvajal. Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study. Eur J Clin Pharmacol (2013) 69:559\u2013564.<\/li>\n<li>D\u2019Incau P, Lapeyre-Mestre M, Carvajal A, Donati M, Salado I, Rodriguez L, S\u00e1inz M, Escudero A, Conforti A. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain. Fundam Clin Pharmacol. 2013 Apr 11. DOI: <a href=\"https:\/\/doi.org\/10.1111\/fcp.12032\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1111\/fcp.12032<\/a>. [Epub ahead of print].<\/li>\n<li>Odile Sauzet, Alfonso Carvajal, Antonio Escudero, Mariam Molokhia, Victoria R. Cornelius. Illustration of the Weibull Shape Parameter Signal Detection Tool Using Electronic Healthcare Record Data. Drug Saf 2013;36 (10):995-1006.<\/li>\n<li>Jimeno N, Velasco V, Escudero A, Guerro D, G\u00f3mez R, Prieto R, Carvajal A. Estudio multidisciplinar de seguimiento del peso corporal en una cohorte de pacientes en tratamiento inicial con antipsic\u00f3ticos. Anales de la Real Academia de Medicina y Cirug\u00eda de Valladolid, en prensa.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2012<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Trece\u00f1o C, Mart\u00edn Arias LH, S\u00e1inz M, Salado I, Garc\u00eda Ortega P, Velasco V, Jimeno N, Escudero A, Velasco A, Carvajal A. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y Le\u00f3n (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate. Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):435-41.<\/li>\n<li>Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, Ge D, Shianna KV, Daly AK, Lucena MI, Nelson MR, Molokhia M, Aithal GP, Floratos A, Pe\u2019er I, Serrano J, Bonkovsky H, Davern TJ, Lee WM, Navarro VJ, Talwalkar JA, Goldstein DB, Watkins PB; Drug-Induced Liver Injury Network; DILIGEN; EUDRAGENE; Spanish DILI Registry; International Serious Adverse Events Consortium. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics. 2012 Nov;22(11):784-95. DOI: <a href=\"http:\/\/doi.org\/10.1097\/FPC.0b013e3283589a76\" target=\"_blank\" rel=\"noopener\">http:\/\/doi.org\/10.1097\/FPC.0b013e3283589a76<\/a>.<\/li>\n<li>Trece\u00f1o C, Mart\u00edn Arias LH, S\u00e1inz M, Salado I, Garc\u00eda Ortega P, Velasco V, Jimeno N, Escudero A, Velasco A, Carvajal A. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y Le\u00f3n (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate. Pharmacoepidemiol Drug Saf 2012; Jan 17. DOI: <a href=\"http:\/\/doi.org\/10.1002\/pds.2348\" target=\"_blank\" rel=\"noopener\">http:\/\/doi.org\/10.1002\/pds.2348<\/a>.<\/li>\n<li>Arias LH, Trece\u00f1o C, Garc\u00eda-Ortega P, Rodr\u00edguez-Paredes J, Escudero A, S\u00e1inz M, Salado I, Velasco V, Carvajal A.\u00a0Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study.\u00a0Eur J Clin Pharmacol. 2012; Jul 21.<\/li>\n<li>Ag\u00fandez JA, Abad-Santos F, Aldea A, Alonso-Navarro H, Bernal ML, Borobia AM, Borr\u00e1s E, Carballo M Carvajal A. Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene\/drug pairs and barriers perceived in Spain. Frontiers in Genetics 2012; 3 (November 2012): 1-4.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2011<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Carvajal A, Ortega PG, S\u00e1inz M, Velasco V, Salado I, Arias LH, Eiros JM, Rubio AP, Castrodeza J. Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting. Vaccine 2011; 10; 29(3):519-22.<\/li>\n<li>Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BH, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe\u2019er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK; Spanish DILI Registry; EUDRAGENE; DILIN; DILIGEN; International SAEC. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011; 141(1):338-47.<\/li>\n<li>Carvajal A, Ortega S, Del Olmo L, Vidal X, Aguirre C, Ruiz B, Conforti A, Leone R, L\u00f3pez-V\u00e1zquez P, Figueiras A, Ib\u00e1\u00f1ez L. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study. PLoS One 2011; 6(5):e19819.<\/li>\n<li>Ubeira FM, Anad\u00f3n AM, Salgado A, Carvajal A, Ortega S, Aguirre C, L\u00f3pez-Goikoetxea MJ, Ibanez L, Figueiras A. Synergism between prior Anisakis simplex infections and intake of NSAIDs, on the risk of upper digestive bleeding: a case-control study. PLoS Negl Trop Dis 2011; 5(6):e1214.<\/li>\n<li>Ruiz Rebollo ML, Aller De La Fuente R, Macho Conesa A, Salado Valdivieso I, Sainz Gil M, Carvajal A, Manuel Gonz\u00e1lez J. [Amoxicillin-induced cholestatic hepatitis].\u00a0Gastroenterol Hepatol 2011; 34(7):474-7.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2010<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Arias LH, Lobato CT, Ortega S, Velasco A, Carvajal A, del Pozo JG.\u00a0Trends in the consumption of antidepressants in Castilla y Le\u00f3n (Spain). Association between suicide rates and antidepressant drug consumption. Pharmacoepidemiol Drug Saf 2010; 19(9): 895-900.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2009<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Carvajal A, Mac\u00edas D, Salado I,\u00a0 Sainz M, Ortega S, Campo C,\u00a0 Garc\u00eda del Pozo J,\u00a0 Mart\u00edn Arias LH,\u00a0 Velasco A, Gon\u00e7alves S,\u00a0 Pombal R,\u00a0 Carmona R. Heart Rhythm Disturbances Associated With Rupatadine: A Case Series From the Spanish and Portuguese Pharmacovigilance Systems. Clin Pharmacol Ther 2009; 85(5):481-4.<\/li>\n<li>Sainz M, Garc\u00eda del Pozo J, Mart\u00edn Arias LH, Velasco A, Carvajal A. Alopecia induced by strontium ranelate. A case series from the Spanish Pharmacovigilance System and a case\/non-case approach.\u00a0BMJ 2009; 338:b1494.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2008<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Garc\u00eda del Pozo J, Carvajal A, Viloria JM, Velasco A, Garc\u00eda del Pozo V. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol . 2008 Apr;64(4):411-5. ( Epub 2007 Dec 20).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2007<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Garcia Del Pozo J, Carvajal A, Viloria JM, Velasco A, Garcia Del Pozo V. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol. 2007 Dec 20; [Epub ahead of print] (on-line).<\/li>\n<li>Carvajal A, Macias D, Guti\u00e9rrez A, Ortega S, S\u00e1inz M, Mart\u00edn Arias LH, Velasco A. Gynaecomastia associated with proton pump inhibitors: a cas e series from the Spanish Pharmacovigilance System. Drug Saf 2007;30(6):527-31.<\/li>\n<li>Pachkoria D, Lucena MI, Molokhia M, Cueto R, Serrano Carballo A, Carvajal A, Andrade RJ. Genetic and molecular factors in drug-induced liver injury: a review. Current Drug Safety. 2007;2(2):97-112.<\/li>\n<li>Carvajal A, Mac\u00edas D. Clozapine and aneurysm. WHO Signal. March 2007. The Uppsala Monitoring Centre.<\/li>\n<li>Carvajal A. Informe sobre la situaci\u00f3n sanitaria en los campamentos de refugiados del Sahara Occidental. Propuesta para establecer un programa de cooperaci\u00f3n de la Universidad de Valladolid. Cl\u00ednica 2007; 16:65-70.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2006<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Lapeyre-Mestre M, De Castro Am, Bareille Mp, Pozo Jg, Requejo Aa, Arias Lm, Montastruc Jl, Carvajal A. Non-Steroidal anti-inflammatory drug-related hepatic damage in France and Spain : analysis from national spontaneous reporting systems. Fundam Clin Pharmacol. 2006;20(4);391-5.<\/li>\n<li>Carvajal A, Macias D, Sainz M, Ortega S, Martin Arias Lh, Velasco A, Bagheri H, Lapeyre-Mestre M, Montastruc JL HMG CoA Reductase Inhibitors and Impotence: Two Case Series from the Spanish and French Drug Monitoring Systems. Drug Saf. 2006;29(2):143-9.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2004<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Velasco Mart\u00edn A, Gil Zorzo Jr, Garc\u00eda Del Pozo J, Carvajal Garc\u00eda-Pando A. Evoluci\u00f3n del consumo de antiepil\u00e9pticos y antiparkinsonianos en Espa\u00f1a durante el periodo 1990-1999. Anales de la Real Academia de Medicina y Cirug\u00eda de Valladolid 2004:183-191.<\/li>\n<li>Carvajal A, Mart\u00edn Arias LH, Vega E, Garc\u00eda S\u00e1nchez JA, Mart\u00edn Rodr\u00edguez I, Garc\u00eda Ortega P, Garc\u00eda Del Pozo J. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study. Eur J Clin Pharmacol 2004; 60:439-444.<\/li>\n<li>Garc\u00eda Del Pozo J, De Abajo Iglesias FJ, Carvajal Garc\u00eda-Pando A, Montero Corominas D, Madurga Sanz M, Garc\u00eda Del Pozo V. Utilizaci\u00f3n de ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a (1995-2002). Rev Esp Salud P\u00fablica 2004; 78:379-387.<\/li>\n<li>Garc\u00eda del Pozo J, Garc\u00eda del Pozo V, S\u00e1inz Gil M, Carvajal Garc\u00eda-Pando A. Utilizaci\u00f3n de medicamentos para la osteoporosis en Espa\u00f1a. Aten Primaria 2004; 33:104-105.<\/li>\n<li>T Walley, P. Folino-Gallo, U Schwabe &amp; E Van Ganse, on behalf of the EuroMedStat group &amp; P Stephens (I. Rosian, S. Vogler, R. van der Stichele, L. Larsen, B. \u00d8degaard, A.K. Brahm, J. Martikainen, E. van Ganse, G. Pietri, U. Schwabe, A. Linos, E. Riza, M. Barry, L. Tilson, P. Folino (co-ordinator), F. Palazzo, G. Stirparo, A. Righi, M. Bruzzone, E. Puca, N. Martini, G. Ozolins (observer), P. Jansen, D. Genees, M. R\u00f8nning, I. Litleskare, A. Faria Vaz, A. Antonio, A. Carvajal, M. S\u00e1inz, K. Antonov , A. Carlsten, T. Walley, K. de Joncheere). Comparison of National Administrative and Commercial Databases to Monitor Expenditure and Costs of Statins Across Europe. Eur J Clin Pharmacol 2004 (in press).<\/li>\n<li>T Walley, P Folino-Gallo, U Schwabe, E van Ganse on behalf of the EuroMedStat Group (I. Rosian, S. Vogler, R. van der Stichele, L. Larsen, B. \u00d8degaard, A.K. Brahm, J. Martikainen, E. van Ganse, G. Pietri, U. Schwabe, A. Linos, E. Riza, M. Barry, L. Tilson, P. Folino (co-ordinator), F. Palazzo, G. Stirparo, A. Righi, M. Bruzzone, E. Puca, N. Martini, G. Ozolins (observer), P. Jansen, D. Genees, M. R\u00f8nning, I. Litleskare, A. Faria Vaz, A. Antonio, A. Carvajal, M. S\u00e1inz, K. Antonov, A. Carlsten, T. Walley, K. de Joncheere). Variations and increase in use of statins across Europe: data from administrative database. BMJ 2004, 328: 385-6.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2003<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Folino-Gallo, T. Walley, K. deJoncheere, R. vander Stichele. EURO-MED-STAT: Monitoring expenditure and utilisation of medicinal products in the European Union countries: A public health approach. In W.Kirch (editor): Public Health in Europe 10 years EUPHA. Selected manuscripts from the 10th Annual Congress of the European Public Health Association 28-30 November 2002. Dresden Germany Springer Verlag Berlin 2003 (ISBN 3-540-40240-3)<\/li>\n<li>THE EURO-MED-STAT GROUP. EURO-MED-STAT: Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach. Eur J Public Health 2003; 13 (3 Suppl): 95-100.<\/li>\n<li>Garc\u00eda del Pozo J, Isusi Lomas L, Carvajal Garc\u00eda-Pando A, Mart\u00edn Rodr\u00edguez I, S\u00e1inz Gil M, Garc\u00eda Del Pozo V, Velasco Mart\u00edn A. Evoluci\u00f3n del consumo de f\u00e1rmacos antipsic\u00f3ticos en Castilla y Le\u00f3n (1990-2001). Rev Esp Salud P\u00fablica 2003; 77: 725-733.<\/li>\n<li>S\u00e1inz M, Carvajal A, Folino Gallo P, Garc\u00eda Del Pozo J. Oferta de medicamentos en la Uni\u00f3n Europea. El caso de los antiagregantes plaquetarios. Med Clin (Barc) 2003; 120 (20):793-5.<\/li>\n<li>Carvajal A, Macia MA, Garc\u00eda Del Pozo J, De Abajo F, Montero D, de Andres-Trelles F. Small risk ratios may have strong public health impact. BMJ 2003; 327:1050-51.<\/li>\n<li>Carvajal A. \u201cMedicalisation\u201d et effets indesirables medicamenteux (P. Montastruc). Bulletin d\u2019Informations de Pharmacologie (BIP) 2003, 9, Suppl, S1-S4.<\/li>\n<li>Garc\u00eda Del Pozo J, Carvajal A, Grajal C, Vera E, del Pino A. Antimigraine drug consumption in Spain (1990-2000). Acta Neurol Scand 2003;107:158-160<\/li>\n<li>Carvajal A. El compromiso del farmac\u00f3logo cl\u00ednico. ICB digital 2003;11:2-3.<\/li>\n<li>Lucena MI, Carvajal A, Andrade RJ, Velasco A. Antidepressant-induced hepatotoxicity. Expert Opinion on Drug Safety 2003;2(3):249-262.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2002<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Garc\u00eda Del Pozo J, Carvajal A, Velasco A. Utilizaci\u00f3n de ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a (1995-2001). Anales de la Real Academia de Medicina y Cirug\u00eda de Valladolid 2002;XL:181-191.<\/li>\n<li>Carvajal A, Garc\u00eda Del Pozo J, S\u00e1nchez S\u00e1nchez A, Velasco Mart\u00edn A, Rueda de Castro AM, Lucena I. Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry 2002;63:135-7.<\/li>\n<li>Vega Cubillo E, Garc\u00eda S\u00e1nchez JA, Garc\u00eda Ortega P, Carvajal A. La investigaci\u00f3n en atenci\u00f3n primaria debe ser potenciada. Aten Primaria 2002;30:97.<\/li>\n<li>Benet Rodr\u00edguez M, Carvajal A, Garc\u00eda del Pozo J, \u00c1lvarez Requejo A, Vega Alonso T. Tratamiento hormonal sustitutivo en Espa\u00f1a. Un estudio de utilizaci\u00f3n. Med Clin 2002;119:4-8.<\/li>\n<li>Garc\u00eda del Pozo J, Mateos Campos R, Garc\u00eda del Pozo V, Benet Rodr\u00edguez M, Carvajal A, Vera S\u00e1nchez V. Trends in the use of antiasthmatics in Spain (1989-1998). Clin Drug Invest 2002;22:709-13.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo, Vera E, del Pino A. Hepatotoxicity associated with nimesulide: Data from the Spanish Pharmacovigilance System. Clin Pharm &amp; Therap 2002;72:596-7.<\/li>\n<li>Carvajal A. Los otros riesgos de los medicamentos: el caso del paracetamol. Med Clin 2002;119:639.<\/li>\n<li>Carvajal A, Montero D. MedDRA: Una terminolog\u00eda para la armonizaci\u00f3n en materia de medicamentos. ICB digital 2002;10:2-5.<\/li>\n<li>Garc\u00eda del Pozo G, Carvajal A, Grajal C, Vera E, Del Pino A. Antimigraine drug consumption in Spain (1999-2000). Acta Neurol Scand 2002;106:1-3.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2001<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Cuervo JR, Garcia Ortega P, Sanchez A, Carvajal A. Ginecomastia asociada al uso concomitante de cisaprida y lansoprazol. Med Clin 2001;116:437-8.<\/li>\n<li>Garc\u00eda Ortega P, Navarro JJ, Carvajal A, Garc\u00eda del Pozo J. Hepatitis colest\u00e1sica por ticlopidina. Med Clin 2001;116:117.<\/li>\n<li>Jabary N, Carvajal A, Garc\u00eda del Pozo J. The use of antihypertensive therapy. Am J Hypertension 2001;14:600-1.<\/li>\n<li>Folino-Gallo P, Walley T, Frolich JC, Carvajal A, Edwards R. Availability of medicines in the European Union: results from the EURO-medicines project. Eur J Clin Pharmacol 2001;57:441-446.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>2000<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Rodr\u00edguez JC, Albadejo C, S\u00e1nchez A, Carvajal A, Mart\u00edn Arias LH, Garc\u00eda del Pozo J. Withdrawal syndrome after long-term treatment with tramadol . Br J Gen Pract 2000;50:406.<\/li>\n<li>Ortiz de Urbina JJ, Gonz\u00e1lez JM, S\u00e1nchez A, Carvajal A. Urinary incontinence due to carbamazepine: A case report. Eur Hosp. Pharmacy 2000;6:106.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo J, Mart\u00edn De Diego I, Rueda AM, Velasco A. Efficacy on fenfluramine and dexfenfluramine in the treatment of obesity: A meta-analysis. Meth Find Exp Clin Pharmacol 2000;22:285-290.<\/li>\n<li>Garc\u00eda del Pozo J, Barcenilla A, Garc\u00eda del Pozo D, Velasco A, Carvajal A. The evolution of the consumption of antidiabetics in Spain during the period 1989-1998. Pharm Care Esp 2000;2:348-356.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo J, Benet M, Mart\u00edn Arias LH, Rueda de Castro AM. Utilisation of lipid lowering drugs in Spain between 1986 and 1998. Clin Drug Invest 2000;20(3):197-201.<\/li>\n<li>Urrutia M, \u00c1lvarez I, S\u00e1nchez A, Carvajal A, Mart\u00edn Arias LH, Garc\u00eda del Pozo J. Doxazosine and priapism. J Urol 2000;163:238.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1999<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Hidalgo Balsera A, Garc\u00eda del Pozo J, Carvajal A. Mortalidad y morbilidad producida por f\u00e1rmacos. Aproximaci\u00f3n a su magnitud en nuestro medio. Pharm Care Esp 1999;1:179-183.<\/li>\n<li>Garc\u00eda del Pozo J, Carvajal Garc\u00eda-Pando A, Rueda AM, Mart\u00edn Arias LH. El ensayo cl\u00ednico no garantiza la seguridad de los medicamentos. A prop\u00f3sito del caso de la fenfluramina y dexfenfluramina. Medicina cl\u00ednica 1999;113(15):598.<\/li>\n<li>Garc\u00eda del Pozo J, Carvajal A, Rueda AM, Cano MI, Mart\u00edn Arias LH. Opioid consumption in Spain. The significance of an intervention. Eur J Clin Pharmacol 1999;55:681-683.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo J, Rueda AM, Martin Arias LH, S\u00e1nchez A. Desarrollo y proyecciones de la Farmacoepidemiolog\u00eda. Farmacoterapia 1999;5-6:229-233.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo J, Rueda AM, Martin Arias LH, S\u00e1nchez A. El consumo de medicamentos como indicador sanitario. Farmacoterapia 1999;5-6:229-233.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo J, Rueda AM, Martin Arias LH, S\u00e1nchez A. Novedades y progreso en terap\u00e9utica. Problemas de seguridad de los medicamentos. Farmacoterapia 1999;5-6:246-251.<\/li>\n<li>Carvajal A y Grupo de investigaci\u00f3n sobre la vacuna antimeningoc\u00f3cica del Sistema Espa\u00f1ol de Farmacovigilancia. Seguridad de la vacuna antimeningoc\u00f3cica A+C. Datos recogidos por el Sistema Espa\u00f1ol de Farmacovigilancia. Gaceta Sanitaria 1999;13:462-467.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo J, Del Olmo L, Rueda AM, \u00c1lvarez Requejo A. Consumo de f\u00e1rmacos antiulcerosos Atenci\u00f3n Primaria 1999;23:218-221.<\/li>\n<li>Carvajal A, Garc\u00eda Ortega P, Rueda Castro AM, Garc\u00eda del Pozo J. Ticlopidina y reacciones adversas hep\u00e1ticas. Datos recogidos por el Sistema Espa\u00f1ol de Farmacovigilancia. Medicina Cl\u00ednica 1999; 112:557-558.<\/li>\n<li>Carvajal A, Garc\u00eda del Pozo J, \u00c1lvarez Requejo A, Mart\u00edn Arias LH. El consumo de medicamentos opiodes en Espa\u00f1a. El papel de la code\u00edna. Medicina cl\u00ednica 1999; 112:237-238.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1998<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>\u00c1lvarez Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Mart\u00edn Arias LH. Under-reporting of adverse drug reactions. Eur J Clin Pharmacol 1998;54:483-488.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>\u00a0<\/strong><strong>1997<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Carvajal A, Garc\u00eda del Pozo J, Mart\u00edn Arias LH, Mart\u00edn De Diego I, Rueda AM, Caro-Paton T, \u00c1lvarez Requejo A. Cambios en el patr\u00f3n de consumo de analg\u00e9sicos opiodes en Espa\u00f1a. Medicina Cl\u00ednica 1997;10:281-283.<\/li>\n<li>Carvajal A, Mart\u00edn Arias LH. Antipsychotic drugs to the millenium. Eur J Clin Pharmacology 1997;52:163.<\/li>\n<li>Tejada M, Llavona AM, Mart\u00edn Arias LH, Carvajal A. Terbinafina y hepatitis colest\u00e1sica. Medicina Cl\u00ednica 1997;109:356.<\/li>\n<li>Caro-Pat\u00f3n T, Carvajal A, Mart\u00edn De Diego I, Mart\u00edn Arias LH, \u00c1lvarez Requejo A, Rodr\u00edguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997:44:179-182.<\/li>\n<li>Viana de Miguel C, \u00c1lvarez M, S\u00e1nchez A, Carvajal A. Hepatitis inducida por lansoprazol. Medicina Cl\u00ednica 1997;108:599.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1996<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Alvarez Requejo A, Mart\u00edn Arias LH, Carvajal A. Farmacovigilancia y vigilancia de salud p\u00fablica. Gaceta Sanitaria 1996; 10:152-3.<\/li>\n<li>Carvajal A, Caro-Pat\u00f3n T, Mart\u00edn De Diego I, Mart\u00edn Arias LH, \u00c1lvarez Requejo A, Lobato A. Vacuna DTP y s\u00edndrome s\u00fabita del lactante. Medicina Cl\u00ednica 1996. Un meta-an\u00e1lisis; 106: 649-652.<\/li>\n<li>Mart\u00edn Arias LH, Carvajal A, Caro-Pat\u00f3n T, Revilla F. Metrorragias producidas por la aplicaci\u00f3n t\u00f3pica de medroxiprogesterona. \u00bfMerece la pena? Medicina Cl\u00ednica 1996; 106:356.<\/li>\n<li>Carvajal A, Prieto JR, \u00c1lvarez Requejo A, Mart\u00edn Arias LH. Aspirin or acetaminophen? A comparison from data collected by the Spanish Drug Monitoring System. Clin Epidemiol 1996; 49:255-261.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1995<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Mart\u00edn Arias LH, Carvajal A, Mart\u00edn De Diego I, De Abajo F. Before and after triazolam: changes in the consumption of hypnotics in Spain. Br J Clin Pharmacol 1995;40: 289-290.<\/li>\n<li>Carvajal A, L\u00e9rida MT, S\u00e1nchez A, Mart\u00edn Arias LH, Mart\u00edn De Diego I. ACE inhibitors and impotente: a case series from the Spanish Drug Monitoring System. Drug Safety 1995; 13:130-131.<\/li>\n<li>Marcos Olea JL, Alonso Prieto MI, Mart\u00edn Arias LH, S\u00e1nchez S\u00e1nchez A, Carvajal A. Ginecomastia producida por nifedipino. Atenci\u00f3n Primaria 1995;16:115-116.<\/li>\n<li>Carvajal A, Mart\u00edn Arias LH. Gynecomastia and sexual disorders after the administration of omeprazole. Am J Gastroenterology 1995; 90:1028-29.<\/li>\n<li>Carvajal A, S\u00e1nchez A, Hurarte G. Metronidazole during pregnancy. Int J Gyn Obst 1995; 48:323-324.<\/li>\n<li>Carvajal A, S\u00e1nchez A. El caso y su control. Medicina cl\u00ednica 1995; 104:560.<\/li>\n<li>Carvajal A, Mart\u00edn Ari as L, Mart\u00edn De Diego I, Velasco A. Aspirin and paracetamol changing pattern of use in Spain. Pharmacoepidemiol Drug Saf 1995;4:281-2.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1994<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Eyaralar MT, L\u00e9rida MT, S\u00e1nchez A, Ortiz de Urbina JJ, Carvajal A. Alteraciones neurol\u00f3gicas graves y sialorrea en un paciente anciano tratado con ciprofloxacino. Rev Esp Neurol 1994; 9:45.<\/li>\n<li>Gil Garc\u00eda JF, L\u00e9rida Arias MT, Del Pozo Hernando LJ, Carvajal A. Erupci\u00f3n fija medicamentosa por amoxicilina. Medicina Cl\u00ednica 1994;102:438.<\/li>\n<li>Padr\u00f3n VF, S\u00e1nchez A, L\u00e9rida MT, Carvajal A. Neuritis \u00f3ptica aparecida en el curso de un tratamiento con clomifeno. Atenci\u00f3n Primaria. 1994;14:86-87.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1993<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Calder\u00f3n J, Pajares MM, Mart\u00edn Arias LH, Carvajal A. Alteraciones neurol\u00f3gicas debidas a diclofenaco. Medicina Cl\u00ednica 1993; 101:76.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1992<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Pozo Rom\u00e1n T, Ramos I, Garc\u00eda Ortiz A, Carvajal A. Ictiosis adquirida producida por f\u00e1rmacos. Actas Dermo-Sifilogr\u00e1ficas 1992; Abril:236.<\/li>\n<li>Muro Uria G, Abad Lecha E, Mart\u00edn Arias, Carvajal A. Aumento del n\u00famero de ausencias tras la exposici\u00f3n a amoxicilina\/\u00e1cido clavul\u00e1nico. Medicina Cl\u00ednica 1992; 20:793-794.<\/li>\n<li>Moreno M, Ruiz D, Ramos I, Mart\u00edn Arias LH, Carvajal A. Hipoglucemia secundaria a tenoxicam. Rev Clin Esp 1992; 191: 68-69.<\/li>\n<li>S\u00e1nchez de Dios M, S\u00e1nchez S\u00e1nchez A, Garc\u00eda Ortiz A, Carvajal A. \u00bfP\u00farpura anafilactoide de Sch\u00f6nlein-Henoch producida por midecamicina? Rev Clin Esp 1992;191(4):230-1.<\/li>\n<li>Vaquero MA, Mart\u00edn Arias LH, Salda\u00f1a D, Carvajal A. Comunicaci\u00f3n de un caso de galactorrea en paciente tratada con teofilina. Rev Clin Esp 1992; 48-49.<\/li>\n<li>Ramos I, Gonz\u00e1lez Gero Y, Carvajal A. Muerte por anemia apl\u00e1sica producida por D-penicilamina. Farm Hosp 1992; 16:352-354.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1991<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Jim\u00e9nez G\u00f3mez R, Salda\u00f1a D, Mart\u00edn Arias LH, Carvajal A. Somnolencia en el tratamiento con diosmina. Medicina Cl\u00ednica 1991; 97:198-199.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1990<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Sanz Cantalapiedra R, Dalf\u00f3 A, Mart\u00edn Arias LH, Carvajal A. Hiperplasia gingival producida por nifedipina; Atenci\u00f3n Primaria 1990;7:160.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1989<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Espino P, Carvajal A, Mart\u00edn Arias LH. Consumo de antiepil\u00e9pticos en Castilla y Le\u00f3n. Rev Esp Neurol 1989;4:525-526.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1988<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Carvajal A, Mart\u00edn Arias LH. Programa de notificaci\u00f3n Voluntaria de Reacciones Adversas a Medicamentos en Castilla y Le\u00f3n. Salud P\u00fablica 1988; 1: 279-282.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>1986<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Carvajal A, Mart\u00edn Arias LH, Revilla Ramos F, Ordax J. Sobre los estudios de medicamentos 1986 . Atenci\u00f3n Primaria ;3:51-52.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>\u00a01985<\/strong><\/h3>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Carvajal A, Mart\u00edn Arias, Revilla F, Ordax J. Consumo de medicamentos por subgrupos terap\u00e9uticos en las provincias de Valladolid y Le\u00f3n. Atenci\u00f3n Primaria 1985;2:274-278.<\/li>\n<li>Carvajal A, Mart\u00edn Arias LH, Revilla F, Ordax J. Declaraci\u00f3n de tuberculosis y consumo de tuberculost\u00e1ticos en las provincias de Le\u00f3n y Valladolid. Medicina Cl\u00ednica 1985;84:758.<\/li>\n<li>Mart\u00edn Arias LH, Carvajal A, De Frutos Mart\u00edn P. Evoluci\u00f3n del consumo de medicamentos en Valladolid y provincia. Medicina Cl\u00ednica 1985;84:758.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"[vc_row][vc_column][vc_column_text][\/vc_column_text][vc_column_text] Publicaciones Libros y cap\u00edtulos de libros Salgueiro ME, Gil MA, Jimeno FJ, Perez B, S\u00e1inz M, Esteban C. La farmacovigilancia y los profesionales sanitarios. En: Los primeros 25 a\u00f1os del Sistema Espa\u00f1ol de Farmacovigilancia de Medicamentos de Uso Humano. Oviedo: Universidad de Oviedo; 2010 p. 93-120. Art\u00edculos cient\u00edficos 2025 Yuste, M.T., Sainz-Gil, M., Escudero, [&hellip;]\n","protected":false},"author":101011,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-977","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/pages\/977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/comments?post=977"}],"version-history":[{"count":10,"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/pages\/977\/revisions"}],"predecessor-version":[{"id":1024,"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/pages\/977\/revisions\/1024"}],"wp:attachment":[{"href":"https:\/\/albergueweb1.uva.es\/cesme\/wp-json\/wp\/v2\/media?parent=977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}